Nn Littlecorn, the new trial for both G1 and G3 patients for a 12 week dosing period. Once again this puts to bed the silly comments somebody was making about Biotron deliberately avoiding G1 patients LOL. Who was that?
PS. Did I mention that the trial is fully funded therefore no need for a CR?
this should have a market cap of 100 million +, page-111
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 848023 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 1015620 | 3 |
View Market Depth
| Last trade - 10.25am 01/10/2024 (20 minute delay) ? |
| BIT (ASX) Chart |
Day chart unavailable